Want to see EXPO full AI Analyst Report?
EXPO Stock Chart & Stats
$68.05
$0.25(0.29%)
At close: 4:00 PM EST
$68.05
$0.25(0.29%)
Day’s Range― - ―
52-Week Range$51.91 - $81.95
Previous CloseN/A
Volume38.01K
Average Volume (3M)598.18K
Market Cap
$2.96B
Enterprise Value$2.73B
Total Cash (Recent Filing)$118.55M
Total Debt (Recent Filing)$81.04M
Price to Earnings (P/E)28.4
Beta0.76
Next Earnings
Jul 23, 2026EPS Estimate
0.55Next Dividend Ex-DateN/A
Dividend Yield1.66%
Share Statistics
EPS (TTM)2.15
Shares Outstanding48,511,627
10 Day Avg. Volume671,252
30 Day Avg. Volume598,179
Financial Highlights & Ratios
PEG Ratio-14.37
Price to Book (P/B)9.15
Price to Sales (P/S)6.14
P/FCF Ratio29.19
Enterprise Value/Market Cap0.92
Enterprise Value/Revenue4.53
Enterprise Value/Gross Profit19.02
Enterprise Value/Ebitda16.84
Forecast
1Y Price Target
$73.96Price Target Upside8.69% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering4
EPS Forecast (FY)2.26
Revenue Forecast (FY)$580.77M
Bulls Say, Bears Say
Bulls Say
AI-driven Revenue OpportunitiesManagement indicates certain business segments can capture new revenue from AI-related work, including increased demand for user research tied to AI-enabled devices.
Cash Flow And Capital AllocationRobust free cash flow and flexible capital allocation support shareholder returns via dividends and share repurchases and provide resilience through economic cycles.
GuidanceAnalyst notes management's guidance appears conservative relative to consensus, creating potential upside for the shares if execution meets or exceeds expectations.
Bears Say
Contract CancellationsAnalysts flag that contract cancellations could trigger sudden revenue declines and margin pressure if major engagements are terminated.
Skilled Labor ShortagesAnalysts warn shortages of skilled technical personnel could hinder project delivery and raise labor costs, pressuring margins and slowing growth.
Valuation SentimentAnalysts note market concerns about AI have depressed the company's valuation, limiting upside until investor sentiment stabilizes.
Exponent News
EXPO FAQ
What was Exponent’s price range in the past 12 months?
Exponent lowest stock price was $51.91 and its highest was $81.95 in the past 12 months.
What is Exponent’s market cap?
Exponent’s market cap is $2.96B.
When is Exponent’s upcoming earnings report date?
Exponent’s upcoming earnings report date is Jul 23, 2026 which is in 20 days.
How were Exponent’s earnings last quarter?
Exponent released its earnings results on Apr 30, 2026. The company reported $0.59 earnings per share for the quarter, beating the consensus estimate of $0.568 by $0.022.
Is Exponent overvalued?
According to Wall Street analysts Exponent’s price is currently Undervalued.
Does Exponent pay dividends?
Exponent pays a Quarterly dividend of $0.31 which represents an annual dividend yield of 1.66%. See more information on Exponent dividends here
What is Exponent’s EPS estimate?
Exponent’s EPS estimate is 0.55.
How many shares outstanding does Exponent have?
Exponent has 48,511,627 shares outstanding.
What happened to Exponent’s price movement after its last earnings report?
Exponent reported an EPS of $0.59 in its last earnings report, beating expectations of $0.568. Following the earnings report the stock price went down -2.408%.
Which hedge fund is a major shareholder of Exponent?
Currently, no hedge funds are holding shares in EXPO
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Exponent Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$73.96 (8.69% Upside)
$73.96 (8.69% Upside)
Blogger Sentiment
Bullish
EXPO Sentiment 70%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Increased
By 511.9K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $1.0M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 10.1%
Last 30 Days ▼ 3.7%
Last 30 Days ▼ 3.7%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-20.32%
12-Months-Change
Fundamentals
Return on Equity
27.94%
Trailing 12-Months
Asset Growth
-9.94%
Trailing 12-Months
Company Description
Exponent
Exponent, Inc. functions as a global leader in scientific and engineering consulting, operating through its subsidiaries. The firm's activities are divided into two principal segments: Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific division offers a broad spectrum of services encompassing biomechanics, biomedical sciences, structural analysis, civil engineering, construction advisory, data analytics, electrical and computer science, human factors, materials and corrosion science, mechanical engineering, polymer chemistry, thermal dynamics, and vehicle system engineering. Concurrently, the Environmental and Health segment specializes in areas such as chemical regulatory compliance, food safety, ecological and biological studies, earth and environmental sciences, and various health-related scientific fields. With expertise spanning approximately 90 technical disciplines, Exponent is dedicated to addressing complex and pressing issues for its stakeholders. Its client base is diverse, covering industries like chemicals, construction, consumer products, energy, food and beverage, government, life sciences, insurance, manufacturing, technology, heavy industrial equipment, and transportation. The company, originally established in 1967 as The Failure Group, Inc., rebranded as Exponent, Inc. in 1998, and its headquarters are located in Menlo Park, California.
EXPO Company Deck
EXPO Earnings Call
Q1 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call communicated strong operational and financial performance with double-digit top-line growth, expanding EBITDA and margins, increased staffing and utilization, and active capital returns via dividends and substantial buybacks. Management reiterated a confident outlook and maintained full-year guidance, highlighting diversified demand driven by AI integration, energy, data centers, robotics, and medical device work. Headwinds include higher G&A and stock-based compensation costs, modest growth in the environmental & health segment, lower interest income, and some cyclical risk in consumer projects. On balance the positives (robust growth, margin expansion, talent investment, and shareholder returns) materially outweigh the negatives.View all EXPO earnings summariesEXPO Stock 12 Month Forecast
Average Price Target
$73.96
▲(8.69% Upside)
Technical Analysis
Booz Allen
―
Cra International
―
FTI Consulting
―
Huron Consulting
―
Icf International
―
Ownership Overview
1.17% Insiders
30.26% Mutual Funds
1.35% Other Institutional Investors
35.41% Public Companies and
Individual Investors